Announcements Trials
Browse Landscape

Phase

Phase 2 16Phase 3 9Phase 1 4Phase 4 3

Status

Completed 3

Sponsor Class

INDUSTRY 3

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 3

Conditions

Breast Neoplasms 134Neoplasms 112Polycystic Ovary Syndrome 66Prostatic Neoplasms 63Colorectal Neoplasms 51Carcinoma, Non-Small-Cell Lung 47Pain 40Carcinoma, Hepatocellular 35Lung Neoplasms 34Keratosis, Actinic 32Precursor Cell Lymphoblastic Leukemia-Lymphoma 29Pain, Postoperative 26Neoplasm Metastasis 26Head and Neck Neoplasms 26Stomach Neoplasms 24Colonic Neoplasms 23Multiple Myeloma 22Brain Neoplasms 21Pancreatic Neoplasms 20Lymphoma, Follicular 19Leukemia 19Anemia 19Uterine Cervical Neoplasms 18Leukemia, Myeloid, Acute 18Infertility 18Leiomyoma 17Lymphoma, Non-Hodgkin 16Lymphoma 16Cancer Pain 16Leukemia, Myelogenous, Chronic, BCR-ABL Positive 15

Interventions

Erlotinib Hydrochloride 2Platinum Compounds 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 4 × Completed × Non-Squamous Non-Small Cell Lung Cancer × Clear all
NCT01066884 2016-08-24

A Study of First or Second Line Treatment With Tarceva (Erlotinib) in Patients With Advanced Non-Small Cell Lung Cancer

Hoffmann-La Roche

Phase 4 Completed
5 enrolled
Thoracic

Non-Squamous Non-Small Cell Lung Cancer

NCT00451906 2016-05-24

A Study of Avastin (Bevacizumab) in Combination With Platinum-Containing Chemotherapy in Patients With Advanced or Recurrent Non-Squamous Cell Lung Cancer.

Hoffmann-La Roche

Phase 4 Completed
2,252 enrolled 10 charts
Thoracic

Non-Squamous Non-Small Cell Lung Cancer

NCT01609543 2016-02-01

A Study of Tarceva (Erlotinib) in First Line in Patients With Locally Advanced or Metastatic Lung Adenocarcinoma With EGFR Mutations

Hoffmann-La Roche

Phase 4 Completed
62 enrolled 8 charts
Thoracic

Non-Squamous Non-Small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡